173 is the total number of securities Bellevue Asset Management AG has owned. The longest Bellevue Asset Management AG has owned a single stock is 4 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
BIIB | Biogen Inc. | 4 | 4 | 3.42% | 3.90% | 4.17% | Q1 2015 | Q4 2015 | 4 |
CELG | Celgene Corporation | 4 | 4 | 3.63% | 3.83% | 4.05% | Q1 2015 | Q4 2015 | 4 |
GILD | Gilead Sciences, Inc. | 4 | 4 | 3.20% | 3.70% | 4.07% | Q1 2015 | Q4 2015 | 4 |
MDT | Medtronic, Inc. | 4 | 4 | 2.88% | 3.13% | 3.70% | Q1 2015 | Q4 2015 | 4 |
ABT | Abbott Laboratories | 4 | 4 | 2.61% | 3.02% | 3.28% | Q1 2015 | Q4 2015 | 4 |
REGN | Regeneron Pharmaceutic... | 4 | 4 | 1.80% | 2.63% | 3.01% | Q1 2015 | Q4 2015 | 4 |
AMGN | Amgen Inc. | 4 | 4 | 2.06% | 2.57% | 3.04% | Q1 2015 | Q4 2015 | 4 |
ILMN | Illumina, Inc. | 4 | 4 | 1.44% | 2.28% | 2.67% | Q1 2015 | Q4 2015 | 4 |
UNH | UnitedHealth Group Inc... | 4 | 4 | 1.90% | 2.07% | 2.27% | Q1 2015 | Q4 2015 | 4 |
SYK | Stryker Corporation | 4 | 4 | 1.87% | 1.97% | 2.16% | Q1 2015 | Q4 2015 | 4 |
MYL | Mylan Inc. | 4 | 4 | 1.37% | 1.89% | 2.60% | Q1 2015 | Q4 2015 | 4 |
ESRX | Express Scripts Holdin... | 4 | 4 | 1.65% | 1.86% | 2.11% | Q1 2015 | Q4 2015 | 4 |
BDX | Becton, Dickinson and ... | 4 | 4 | 1.17% | 1.85% | 2.47% | Q1 2015 | Q4 2015 | 4 |
ENDP | Endo International PLC | 4 | 4 | 1.45% | 1.73% | 2.08% | Q1 2015 | Q4 2015 | 4 |
ZBH | Zimmer Holdings, Inc. | 4 | 4 | 1.45% | 1.49% | 1.57% | Q1 2015 | Q4 2015 | 4 |
EARS | Auris Medical Holding AG | 4 | 4 | 1.26% | 1.49% | 1.62% | Q1 2015 | Q4 2015 | 4 |
TEVA | Teva Pharmaceuticals, ... | 4 | 4 | 1.22% | 1.48% | 1.77% | Q1 2015 | Q4 2015 | 4 |
CAH | Cardinal Health, Inc. | 4 | 4 | 1.00% | 1.47% | 2.33% | Q1 2015 | Q4 2015 | 4 |
ALXN | Alexion Pharmaceutical... | 4 | 4 | 1.26% | 1.44% | 1.76% | Q1 2015 | Q4 2015 | 4 |
VRTX | Vertex Pharmaceuticals... | 4 | 4 | 1.28% | 1.44% | 1.54% | Q1 2015 | Q4 2015 | 4 |
STJ | St. Jude Medical, Inc. | 4 | 4 | 1.15% | 1.33% | 1.52% | Q1 2015 | Q4 2015 | 4 |
JAZZ | Jazz Pharmaceuticals P... | 4 | 4 | 1.21% | 1.32% | 1.41% | Q1 2015 | Q4 2015 | 4 |
MCK | McKesson Corporation | 4 | 4 | 1.24% | 1.28% | 1.29% | Q1 2015 | Q4 2015 | 4 |
BMRN | BioMarin Pharmaceutica... | 4 | 4 | 1.04% | 1.24% | 1.58% | Q1 2015 | Q4 2015 | 4 |
LGND | Ligand Pharmaceuticals... | 4 | 4 | 1.00% | 1.19% | 1.35% | Q1 2015 | Q4 2015 | 4 |
INCY | Incyte Corporation | 4 | 4 | 0.82% | 1.16% | 1.39% | Q1 2015 | Q4 2015 | 4 |
BSX | Boston Scientific Corp... | 4 | 4 | 0.98% | 1.09% | 1.29% | Q1 2015 | Q4 2015 | 4 |
CI | Cigna Corporation | 4 | 4 | 0.81% | 1.04% | 1.28% | Q1 2015 | Q4 2015 | 4 |
KITE | Kite Pharma, Inc. | 4 | 4 | 0.13% | 1.01% | 1.48% | Q1 2015 | Q4 2015 | 4 |
ISRG | Intuitive Surgical, Inc. | 4 | 4 | 0.91% | 0.96% | 1.02% | Q1 2015 | Q4 2015 | 4 |
MNKKQ | Mallinckrodt public li... | 4 | 4 | 0.77% | 0.92% | 1.24% | Q1 2015 | Q4 2015 | 4 |
CYH | Community Health Syste... | 4 | 4 | 0.51% | 0.91% | 1.30% | Q1 2015 | Q4 2015 | 4 |
AET | Aetna Inc. | 4 | 4 | 0.80% | 0.87% | 0.95% | Q1 2015 | Q4 2015 | 4 |
CVS | CVS Health Corporation | 4 | 4 | 0.43% | 0.86% | 1.43% | Q1 2015 | Q4 2015 | 4 |
PRGO | Perrigo Company plc | 4 | 4 | 0.32% | 0.84% | 1.03% | Q1 2015 | Q4 2015 | 4 |
SHPG | Shire PLC | 4 | 4 | 0.37% | 0.82% | 1.03% | Q1 2015 | Q4 2015 | 4 |
ALKS | Alkermes Public Limite... | 4 | 4 | 0.56% | 0.77% | 0.98% | Q1 2015 | Q4 2015 | 4 |
CHRS | Coherus BioSciences, Inc | 4 | 4 | 0.34% | 0.75% | 1.00% | Q1 2015 | Q4 2015 | 4 |
ABC | AmerisourceBergen Corp... | 4 | 4 | 0.16% | 0.75% | 1.01% | Q1 2015 | Q4 2015 | 4 |
HUM | Humana, Inc. | 4 | 4 | 0.62% | 0.73% | 0.88% | Q1 2015 | Q4 2015 | 4 |
BCR | C.R. Bard, Inc. | 4 | 4 | 0.70% | 0.73% | 0.78% | Q1 2015 | Q4 2015 | 4 |
EW | Edwards Lifesciences C... | 4 | 4 | 0.29% | 0.71% | 1.03% | Q1 2015 | Q4 2015 | 4 |
JNJ | Johnson & Johnson | 4 | 4 | 0.56% | 0.70% | 0.78% | Q1 2015 | Q4 2015 | 4 |
MDVN | Medivation, Inc. | 4 | 4 | 0.36% | 0.69% | 0.98% | Q1 2015 | Q4 2015 | 4 |
CNC | Centene Corporation | 4 | 4 | 0.17% | 0.68% | 1.31% | Q1 2015 | Q4 2015 | 4 |
ANTM | Anthem, Inc. | 4 | 4 | 0.64% | 0.66% | 0.68% | Q1 2015 | Q4 2015 | 4 |
ALNY | Alnylam Pharmaceutical... | 4 | 4 | 0.34% | 0.65% | 0.93% | Q1 2015 | Q4 2015 | 4 |
AGIO | Agios Pharmaceuticals,... | 4 | 4 | 0.53% | 0.64% | 0.76% | Q1 2015 | Q4 2015 | 4 |
HCA | HCA Holdings, Inc. | 4 | 4 | 0.50% | 0.58% | 0.70% | Q1 2015 | Q4 2015 | 4 |
XENT | Intersect Ent, Inc. | 4 | 4 | 0.27% | 0.58% | 0.77% | Q1 2015 | Q4 2015 | 4 |
PFE | Pfizer Inc. | 4 | 4 | 0.44% | 0.58% | 0.87% | Q1 2015 | Q4 2015 | 4 |
BMY | Bristol-Myers Squibb C... | 4 | 4 | 0.54% | 0.58% | 0.63% | Q1 2015 | Q4 2015 | 4 |
CERN | Cerner Corporation | 4 | 4 | 0.53% | 0.57% | 0.67% | Q1 2015 | Q4 2015 | 4 |
ACHN | Achillion Pharmaceutic... | 4 | 4 | 0.46% | 0.56% | 0.69% | Q1 2015 | Q4 2015 | 4 |
CLVS | Clovis Oncology, Inc. | 4 | 4 | 0.28% | 0.55% | 0.82% | Q1 2015 | Q4 2015 | 4 |
ACAD | Acadia Pharmaceuticals... | 4 | 4 | 0.24% | 0.55% | 1.05% | Q1 2015 | Q4 2015 | 4 |
NVAX | Novavax, Inc. | 4 | 4 | 0.38% | 0.55% | 0.80% | Q1 2015 | Q4 2015 | 4 |
THC | Tenet Healthcare Corpo... | 4 | 4 | 0.05% | 0.53% | 0.98% | Q1 2015 | Q4 2015 | 4 |
ARIA | ARIAD Pharmaceuticals,... | 4 | 4 | 0.47% | 0.53% | 0.61% | Q1 2015 | Q4 2015 | 4 |
VAR | Varian Medical Systems... | 4 | 4 | 0.44% | 0.50% | 0.62% | Q1 2015 | Q4 2015 | 4 |
HALO | Halozyme Therapeutics,... | 4 | 4 | 0.18% | 0.46% | 0.84% | Q1 2015 | Q4 2015 | 4 |
MRK | Merck & Co., Inc. | 4 | 4 | 0.32% | 0.46% | 0.55% | Q1 2015 | Q4 2015 | 4 |
TFX | Teleflex Incorporated | 4 | 4 | 0.37% | 0.45% | 0.56% | Q1 2015 | Q4 2015 | 4 |
HOLX | Hologic, Inc. | 4 | 4 | 0.37% | 0.45% | 0.52% | Q1 2015 | Q4 2015 | 4 |
COO | Cooper Companies Inc. | 4 | 4 | 0.38% | 0.44% | 0.48% | Q1 2015 | Q4 2015 | 4 |
NBIX | Neurocrine Biosciences... | 4 | 4 | 0.22% | 0.41% | 0.56% | Q1 2015 | Q4 2015 | 4 |
MASI | Masimo Corporation | 4 | 4 | 0.23% | 0.39% | 0.47% | Q1 2015 | Q4 2015 | 4 |
NKTR | Nektar Therapeutics | 4 | 4 | 0.18% | 0.38% | 0.56% | Q1 2015 | Q4 2015 | 4 |
SRCL | Stericycle, Inc. | 4 | 4 | 0.28% | 0.36% | 0.45% | Q1 2015 | Q4 2015 | 4 |
NUVA | Nuvasive, Inc. | 4 | 4 | 0.29% | 0.33% | 0.37% | Q1 2015 | Q4 2015 | 4 |
TMO | Thermo Fisher Scientif... | 4 | 4 | 0.23% | 0.33% | 0.43% | Q1 2015 | Q4 2015 | 4 |
GMED | Globus Medical, Inc. | 4 | 4 | 0.30% | 0.32% | 0.37% | Q1 2015 | Q4 2015 | 4 |
CLDX | Celldex Therapeutics, ... | 4 | 4 | 0.26% | 0.32% | 0.38% | Q1 2015 | Q4 2015 | 4 |
BLUE | Bluebird Bio, Inc. | 4 | 4 | 0.24% | 0.32% | 0.47% | Q1 2015 | Q4 2015 | 4 |
SGEN | Seattle Genetics, Inc. | 4 | 4 | 0.20% | 0.31% | 0.46% | Q1 2015 | Q4 2015 | 4 |
NVDQ | NOVADAQ TECHNOLOGIES INC | 4 | 4 | 0.13% | 0.30% | 0.48% | Q1 2015 | Q4 2015 | 4 |
MGNX | Macrogenics, Inc. | 4 | 4 | 0.07% | 0.29% | 0.43% | Q1 2015 | Q4 2015 | 4 |
QGEN | QIAGEN NV | 4 | 4 | 0.20% | 0.28% | 0.38% | Q1 2015 | Q4 2015 | 4 |
INO | Inovio Pharmaceuticals... | 4 | 4 | 0.23% | 0.27% | 0.34% | Q1 2015 | Q4 2015 | 4 |
ICPT | Intercept Pharmaceutic... | 4 | 4 | 0.24% | 0.26% | 0.31% | Q1 2015 | Q4 2015 | 4 |
DVA | Davita Healthcare Part... | 4 | 4 | 0.21% | 0.26% | 0.30% | Q1 2015 | Q4 2015 | 4 |
INFI | Infinity Pharmaceutica... | 4 | 4 | 0.18% | 0.23% | 0.32% | Q1 2015 | Q4 2015 | 4 |
HTWR | Heartware Internationa... | 4 | 4 | 0.04% | 0.23% | 0.38% | Q1 2015 | Q4 2015 | 4 |
ANGO | AngioDynamics, Inc. | 4 | 4 | 0.18% | 0.22% | 0.25% | Q1 2015 | Q4 2015 | 4 |
ABBV | Abbvie Inc. | 4 | 4 | 0.14% | 0.22% | 0.25% | Q1 2015 | Q4 2015 | 4 |
UTHR | United Therapeutics Co... | 4 | 4 | 0.20% | 0.22% | 0.22% | Q1 2015 | Q4 2015 | 4 |
WCG | WellCare Health Plans,... | 4 | 4 | 0.10% | 0.21% | 0.28% | Q1 2015 | Q4 2015 | 4 |
LH | Laboratory Corporation... | 4 | 4 | 0.17% | 0.18% | 0.19% | Q1 2015 | Q4 2015 | 4 |
PODD | Insulet Corporation | 4 | 4 | 0.10% | 0.17% | 0.24% | Q1 2015 | Q4 2015 | 4 |
MNKD | MannKind Corporation | 4 | 4 | 0.07% | 0.17% | 0.24% | Q1 2015 | Q4 2015 | 4 |
IPXL | Impax Laboratories, Inc. | 4 | 4 | 0.10% | 0.16% | 0.21% | Q1 2015 | Q4 2015 | 4 |
MYGN | Myriad Genetics, Inc. | 4 | 4 | 0.09% | 0.15% | 0.20% | Q1 2015 | Q4 2015 | 4 |
RMD | ResMed Inc. | 4 | 4 | 0.12% | 0.14% | 0.20% | Q1 2015 | Q4 2015 | 4 |
AFFX | Affymetrix, Inc. | 4 | 4 | 0.11% | 0.13% | 0.18% | Q1 2015 | Q4 2015 | 4 |
ECYT | Endocyte, Inc. | 4 | 4 | 0.06% | 0.11% | 0.17% | Q1 2015 | Q4 2015 | 4 |
EXEL | Exelixis, Inc. | 4 | 4 | 0.05% | 0.11% | 0.15% | Q1 2015 | Q4 2015 | 4 |
XOMA | XOMA Corporation | 4 | 4 | 0.03% | 0.10% | 0.16% | Q1 2015 | Q4 2015 | 4 |
TTPH | Tetraphase Pharmaceuti... | 4 | 4 | 0.03% | 0.05% | 0.08% | Q1 2015 | Q4 2015 | 4 |
TBPH | Theravance Biopharma, ... | 4 | 4 | 0.02% | 0.03% | 0.07% | Q1 2015 | Q4 2015 | 4 |
GERN | Geron Corporation | 4 | 4 | 0.02% | 0.03% | 0.03% | Q1 2015 | Q4 2015 | 4 |
AST | Asterias Biotherapeuti... | 4 | 4 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q4 2015 | 4 |
ISIS | Isis Pharmaceuticals, ... | 3 | 3 | 0.87% | 1.05% | 1.31% | Q1 2015 | Q3 2015 | 3 |
RDY | Dr. Reddy's Laboratori... | 3 | 3 | 0.80% | 1.05% | 1.36% | Q1 2015 | Q3 2015 | 3 |
INSYQ | Insys Therapeutics, Inc. | 3 | 3 | 0.60% | 0.86% | 1.01% | Q2 2015 | Q4 2015 | 3 |
AKRXQ | Akorn, Inc. | 3 | 3 | 0.52% | 0.75% | 0.96% | Q1 2015 | Q3 2015 | 3 |
HZNP | Horizon Pharma plc | 3 | 3 | 0.71% | 0.75% | 0.81% | Q2 2015 | Q4 2015 | 3 |
BAX | Baxter International Inc. | 2 | 1 | 0.27% | 0.75% | 1.33% | Q1 2015 | Q4 2015 | 3 |
XRAY | DENTSPLY International... | 3 | 3 | 0.30% | 0.40% | 0.48% | Q1 2015 | Q3 2015 | 3 |
LLY | Lilly Eli & Co. | 3 | 3 | 0.23% | 0.39% | 0.48% | Q2 2015 | Q4 2015 | 3 |
HCSG | Healthcare Services Gr... | 3 | 3 | 0.30% | 0.33% | 0.36% | Q2 2015 | Q4 2015 | 3 |
JUNO | Juno Therapeutics, Inc. | 3 | 3 | 0.22% | 0.27% | 0.36% | Q2 2015 | Q4 2015 | 3 |
ESPR | Esperion Therapeutics ... | 3 | 3 | 0.14% | 0.20% | 0.31% | Q2 2015 | Q4 2015 | 3 |
IBB | ISHARES TR | 2 | 1 | 0.12% | 0.18% | 0.29% | Q1 2015 | Q4 2015 | 3 |
PRTA | Prothena Corporation plc | 3 | 3 | 0.10% | 0.18% | 0.32% | Q2 2015 | Q4 2015 | 3 |
ELGX | Endologix, Inc. | 3 | 3 | 0.10% | 0.11% | 0.12% | Q1 2015 | Q3 2015 | 3 |
JNP | Juniper Pharmaceutical... | 3 | 3 | 0.08% | 0.10% | 0.14% | Q2 2015 | Q4 2015 | 3 |
DYAX | Dyax Corporation | 3 | 3 | 0.05% | 0.08% | 0.11% | Q1 2015 | Q3 2015 | 3 |
CSII | Cadiovascular Systems ... | 3 | 3 | 0.07% | 0.07% | 0.08% | Q2 2015 | Q4 2015 | 3 |
THRX | Theravance, Inc. | 3 | 3 | 0.04% | 0.07% | 0.09% | Q1 2015 | Q3 2015 | 3 |
CLDN | Celladon Corporation | 3 | 3 | 0.01% | 0.01% | 0.01% | Q2 2015 | Q4 2015 | 3 |
BTXWS | BioTime, Inc. | 2 | 1 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q4 2015 | 3 |
AGN | Allergan PLC | 2 | 2 | 2.08% | 2.15% | 2.22% | Q2 2015 | Q3 2015 | 2 |
RCPT | Receptos, Inc. | 2 | 2 | 0.90% | 1.00% | 1.10% | Q1 2015 | Q2 2015 | 2 |
LCI | Lannett Inc. | 1 | 1 | 0.66% | 0.79% | 0.92% | Q1 2015 | Q4 2015 | 2 |
SUPN | Supernus Pharmaceutica... | 2 | 2 | 0.73% | 0.73% | 0.73% | Q3 2015 | Q4 2015 | 2 |
THOR | Thoratec Corporation | 2 | 2 | 0.32% | 0.33% | 0.34% | Q1 2015 | Q2 2015 | 2 |
DHR | Danaher Corporation | 2 | 2 | 0.22% | 0.23% | 0.23% | Q1 2015 | Q2 2015 | 2 |
ATHN | Athenahealth, Inc. | 2 | 2 | 0.13% | 0.21% | 0.30% | Q1 2015 | Q2 2015 | 2 |
ALDR | Alder Biopharmaceutica... | 2 | 2 | 0.17% | 0.20% | 0.23% | Q3 2015 | Q4 2015 | 2 |
IMMU | Immunomedics, Inc. | 2 | 2 | 0.17% | 0.19% | 0.21% | Q1 2015 | Q2 2015 | 2 |
RLYP | Relypsa, Inc. | 2 | 2 | 0.07% | 0.17% | 0.28% | Q1 2015 | Q2 2015 | 2 |
KANG | iKang Healthcare Group... | 2 | 2 | 0.13% | 0.16% | 0.18% | Q2 2015 | Q3 2015 | 2 |
ABMD | Abiomed, Inc. | 2 | 2 | 0.09% | 0.15% | 0.20% | Q1 2015 | Q2 2015 | 2 |
TMH | Team Health Holdings Inc. | 2 | 2 | 0.10% | 0.12% | 0.13% | Q3 2015 | Q4 2015 | 2 |
MDSO | Medidata Solutions, Inc. | 2 | 2 | 0.08% | 0.11% | 0.14% | Q1 2015 | Q2 2015 | 2 |
ABUS | Arbutus Biopharm Corpo... | 2 | 2 | 0.08% | 0.10% | 0.12% | Q3 2015 | Q4 2015 | 2 |
SGMO | Sangamo Biosciences, Inc. | 2 | 2 | 0.08% | 0.09% | 0.11% | Q1 2015 | Q2 2015 | 2 |
TSRO | Tesaro, Inc. | 2 | 2 | 0.08% | 0.08% | 0.08% | Q1 2015 | Q2 2015 | 2 |
ENTL | Entellus Medical, Inc. | 2 | 2 | 0.07% | 0.08% | 0.09% | Q1 2015 | Q2 2015 | 2 |
TNDM | Tandem Diabetes Care, ... | 2 | 2 | 0.08% | 0.08% | 0.09% | Q1 2015 | Q2 2015 | 2 |
PBYI | Puma Biotechnology, Inc. | 2 | 2 | 0.05% | 0.07% | 0.10% | Q1 2015 | Q2 2015 | 2 |
IMGN | Immunomedics, Inc. | 2 | 2 | 0.05% | 0.05% | 0.06% | Q3 2015 | Q4 2015 | 2 |
PRXL | Parexel International ... | 2 | 2 | 0.04% | 0.05% | 0.05% | Q1 2015 | Q2 2015 | 2 |
CERS | Cerus Corporation | 2 | 2 | 0.03% | 0.05% | 0.06% | Q1 2015 | Q2 2015 | 2 |
T107PS | Wright Medical Group Inc. | 2 | 2 | 0.03% | 0.04% | 0.04% | Q2 2015 | Q3 2015 | 2 |
CTRX | Catamaran Corporation | 1 | 1 | 2.63% | 2.63% | 2.63% | Q1 2015 | Q1 2015 | 1 |
B108PS | Actavis plc | 1 | 1 | 2.02% | 2.02% | 2.02% | Q1 2015 | Q1 2015 | 1 |
IONS | Ionis Pharmaceuticals ... | 1 | 1 | 1.30% | 1.30% | 1.30% | Q4 2015 | Q4 2015 | 1 |
MOH | Molina Healthcare, Inc. | 1 | 1 | 0.89% | 0.89% | 0.89% | Q1 2015 | Q1 2015 | 1 |
EGBN | EAGLE PHARMACEUTICALS INC | 1 | 1 | 0.74% | 0.74% | 0.74% | Q4 2015 | Q4 2015 | 1 |
BKD | Brookdale Senior Livin... | 1 | 1 | 0.71% | 0.71% | 0.71% | Q1 2015 | Q1 2015 | 1 |
ZFGN | Zafgen Inc. | 1 | 1 | 0.52% | 0.52% | 0.52% | Q3 2015 | Q3 2015 | 1 |
RDUS | Radius Health Inc. | 1 | 1 | 0.38% | 0.38% | 0.38% | Q4 2015 | Q4 2015 | 1 |
BIS | Proshares Trust II | 1 | 1 | 0.36% | 0.36% | 0.36% | Q1 2015 | Q1 2015 | 1 |
UBIO | Ultra NASDAQ Biotechno... | 1 | 1 | 0.33% | 0.33% | 0.33% | Q3 2015 | Q3 2015 | 1 |
ZLTQ | Zeltiq Aesthetics Inc. | 1 | 1 | 0.33% | 0.33% | 0.33% | Q4 2015 | Q4 2015 | 1 |
SGNT | Sagent Pharmaceuticals... | 1 | 1 | 0.32% | 0.32% | 0.32% | Q1 2015 | Q1 2015 | 1 |
MDCO | The Medicines Company | 1 | 1 | 0.27% | 0.27% | 0.27% | Q1 2015 | Q1 2015 | 1 |
PTCT | PTC Therapeutics Inc. | 1 | 1 | 0.27% | 0.27% | 0.27% | Q4 2015 | Q4 2015 | 1 |
STE | STERIS Corporation | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2015 | Q1 2015 | 1 |
WMGI | Wright Medical Group Inc. | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2015 | Q4 2015 | 1 |
OCR | Omnicare, Inc. | 1 | 1 | 0.25% | 0.25% | 0.25% | Q1 2015 | Q1 2015 | 1 |
TKMR | Tekmira Pharmaceutical... | 1 | 1 | 0.21% | 0.21% | 0.21% | Q2 2015 | Q2 2015 | 1 |
GEVA | Synageva Biopharma Corp. | 1 | 1 | 0.20% | 0.20% | 0.20% | Q1 2015 | Q1 2015 | 1 |
RARE | Ultragenyx Pharmaceuti... | 1 | 1 | 0.17% | 0.17% | 0.17% | Q4 2015 | Q4 2015 | 1 |
DEPO | Depomed, Inc. | 1 | 1 | 0.17% | 0.17% | 0.17% | Q1 2015 | Q1 2015 | 1 |
CBRX | Columbia Labs Inc. | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2015 | Q1 2015 | 1 |
HNT | Health Net, Inc. | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2015 | Q1 2015 | 1 |
PEN | Penumbra Inc. | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2015 | Q3 2015 | 1 |
GI | EndoChoice Holdings, Inc. | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2015 | Q2 2015 | 1 |
Rewalk Robotics Ltd. | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2015 | Q3 2015 | 1 | |
ISHARES TR | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2015 | Q1 2015 | 1 | |
BTX | Biotime Inc. | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q3 2015 | 1 |
Download |
The securities at the top of the list , including Biogen Inc., Celgene Corporation, and Gilead Sciences, Inc., are the highest-conviction holdings of Bellevue Asset Management AG.
The conviction is calculated by counting the number of quarters a security has been reported by Bellevue Asset Management AG. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Bellevue Asset Management AG owns currently or has owned in the past.